[Pharmacoangiography and pharmacoangiodynography of the penis in erectile dysfunction].
In 80 patients suffering from eretile dysfunction both pharmaco-angiography and pharmaco-Dopplerultrasonography of the penis were performed. The two methods showed a correlation of 96% with regard to the dorsal arteries and 92% with regard to the deep penile arteries. In a further 21 patients with erectile dysfunction pharmaco-angiodynography with the new QUANTUM device from Philips has been performed in recent weeks. The excellent illustration of vasculogenic details, even in the penile periphery, the exact measurement of the relevant hemodynamic parameters, e.g. peak flow velocity or pulsatility index, the short time needed for investigation and its non-invasive character give convincing evidence for the superiority of this new method over conventional angiographic procedures. This is also true when procedures for revascularization of the penis are planned. The only remaining indication for conventional pharmaco-angiography of the penis is now clarification of the connections in posttraumatic impotence of arterial etiology.
Porst
H
H
Urologische Abteilung, Allgemeinen Krankenhauses Harburg, Hamburg-Harburg.
D000527:Alprostadil; D015901:Angiography, Digital Subtraction / Q000379:methods*; D001157:Arterial Occlusive Diseases / Q000175:diagnosis; D001158:Arteries / Q000473:pathology; D001783:Blood Flow Velocity / Q000502:physiology; D007172:Erectile Dysfunction / Q000209:etiology*; D006801:Humans; D008297:Male; D010410:Penile Erection / Q000502:physiology; D010413:Penis / Q000098:blood supply*; D014463:Ultrasonography / Q000379:methods*
D000527:Alprostadil
Pharmakoangiographie und Pharmakoangiodynographie des Penis bei erektiler Dysfunktion.